BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/15/2020 12:32:18 PM | Browse: 1043 | Download: 1398
 |
Received |
|
2019-10-07 16:32 |
|
Peer-Review Started |
|
2019-10-07 16:33 |
|
To Make the First Decision |
|
2019-10-21 02:21 |
|
Return for Revision |
|
2019-10-21 08:31 |
|
Revised |
|
2019-10-29 23:06 |
|
Second Decision |
|
2020-01-05 08:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-01-07 05:09 |
|
Articles in Press |
|
2020-01-07 05:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-01-16 09:58 |
|
Publish the Manuscript Online |
|
2020-02-15 12:32 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Karen Kaiser, Madison Lyleroehr, Sara Shaunfield, Leilani Lacson, Maria Corona, Sheetal Kircher, Malin Nittve and David Cella |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Karen Kaiser, PhD, Associate Professor, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave, Suite 2700, Chicago, IL 60611, United States. k-kaiser@northwestern.edu |
| Key Words |
Neuropathy; Colorectal cancer; Patient reported outcomes; Quality of life; ; |
| Core Tip |
Colorectal cancer patients report significant impairment in dexterity, mobility, and balance due to neuropathy. Because prevention and treatment options for oxaliplatin-induced neuropathy are limited ongoing monitoring and management of neuropathy is important for patient quality of life and treatment adherence. A validated self-reported measure of neuropathy would aid in the management and assessment of neuropathy. This study examined the content validity of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale for colorectal patients with oxaliplatin-induced neuropathy; the measure was found to have content validity for this population. |
| Publish Date |
2020-02-15 12:32 |
| Citation |
Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i2.205 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
